SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001213900-21-009631
Filing Date
2021-02-16
Accepted
2021-02-16 16:27:16
Documents
1
Group Members
C-LSH LLCELI CASDINKEITH A. MEISTERM-LSH LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea135729-13gcmls_cmlife.htm SC 13G 104421
  Complete submission text file 0001213900-21-009631.txt   106022
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10020
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10020 212 474 6700
CM Life Sciences, Inc. (Subject) CIK: 0001818331 (see all company filings)

IRS No.: 851966622 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91664 | Film No.: 21639081
SIC: 6770 Blank Checks

Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 212 474 6745
CMLS Holdings LLC (Filed by) CIK: 0001822257 (see all company filings)

IRS No.: 851989037
Type: SC 13G